Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis

Journal of Clinical Gastroenterology

Volumn 42, Issue 9, 2008, Pages 1047-1053

  Montano Loza, Aldo J ^a   Carpenter, Herschel A ^b   Czaja, Albert J ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

Antimitochondrial antibodies; Autoimmune hepatitis; Primary biliary cirrhosis

Indexed keywords

AZATHIOPRINE; MITOCHONDRION ANTIBODY; PREDNISONE; AUTOANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CHOLESTASIS; CONTROLLED STUDY; DRUG DOSE INCREASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REMISSION; SERODIAGNOSIS; TREATMENT FAILURE; TREATMENT OUTCOME; FOLLOW UP; IMMUNOLOGY; LIVER MITOCHONDRION; MIDDLE AGED; RETROSPECTIVE STUDY; SEROLOGY;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CHOLESTASIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEPATITIS, AUTOIMMUNE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA, LIVER; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEROLOGIC TESTS; TREATMENT OUTCOME;

EID: 58149136329     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181587d18     Document Type: Article

References (51)

1. Fregeau DR, Davis PA, Danner DJ, et al. Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complex. J Immunol. 1989;142: 3815-3820.
2. Van de Water J, Cooper A, Surh CD, et al. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N Engl J Med. 1989; 320:1377-1380.
3. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929-938.
4. Kenny RP, Czaja AJ, Ludwig J, et al. Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis. Dig Dis Sci. 1986;31:705-711.
5. Czaja AJ, Carpenter HA, Manns MP. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology. 1993;105:1522-1528.
6. Nezu S, Tanaka A, Yasui H, et al. Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis. J Gastroenterol Hepatol. 2006;21:1448-1454.
7. Farias AQ, Goncalves LL, Bittencourt PL, et al. Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial/anti-M2 seropositive variant form of autoimmune hepatitis. J Gastroenterol Hepatol. 2006;21:887-893.
8. Lohse AW, Meyer zum Buschenfelde KH, Kanzler FB, et al. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology. 1999;29:1078-1084.
9. Chazouilleres O, Wendum D, Serfaty L, et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology. 1998;28:296-301.
10. Chazouilleres O, Wendum D, Serfaty L, et al. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol. 2006;44:400-406.
11. Angulo P, El-Amin O, Carpenter HA, et al. Development of autoimmune hepatitis in the setting of longstanding primary biliary cirrhosis. Am J Gastroenterol. 2001;96:3021-3027.
12. Poupon R, Chazouilleres O, Corpechot CF, et al. Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis. Hepatology. 2006;44:85-90.
13. Kanda T, Yokosuka O, Hirasawa Y, et al. Occurrence of autoimmune hepatitis during the course of primary biliary cirrhosis: report of two cases. Dig Dis Sci. 2006;51:45-46.
14. Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med. 1996;125:588-598.
15. Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology. 1998;28:360-365.
16. Czaja AJ, Muratori P, Muratori L, et al. Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. Liver Int. 2004;24:322-329.
17. Kayacetin E, Koklu S, Temucin T. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis with unusual initial presentation as fulminant hepatic failure. Dig Liver Dis. 2004;36: 419-422.
18. Renou C, Bourliere M, Martini F, et al. Primary biliary cirrhosisautoimmune hepatitis overlap syndrome: complete biochemical and histological response to therapy with ursodeoxycholic acid. J Gastroenterol Hepatol. 2006;21:781-782.
19. Mackay IR, Gershwin ME. Primary biliary cirrhosis: considerations on pathogenesis based on identification of the M2 autoantigens. Springer Semin Immunopathol. 1990;12:101-119.
20. Neuberger J, Thomson R. PBC and AMA - What is the connection? Hepatology. 1999;29:271-276.
21. Fritzler MJ, Manns MP. Anti-mitochondrial autoantibodies. Clin Appl Immunol Rev. 2002;3:87-113.
22. Van Norstrand MD, Malinchoc M, Lindor KD, et al. Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression. Hepatology. 1997; 25:6-11.
23. Czaja AJ, Manns MP. The validity and importance of subtypes of autoimmune hepatitis: a point of view. Am J Gastroenterol. 1995;90:1206-1211.
24. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36:479-497.
25. Czaja AJ, Cassani F, Cataleta M, et al. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology. 1996;24:1068-1073.
26. Czaja AJ, Cassani F, Cataleta M, et al. Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis. Dig Dis Sci. 1997;42:1688-1696.
27. Homburger HA, Cahen YD, Griffiths J, et al. Detection of antinuclear antibodies. Comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods. Arch Pathol Lab Med. 1998;122:993-999.
28. Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology. 1992; 103: 1290-1295.
29. Omagari K, Rowley MJ, Whittingham S, et al. Autoantibodies to M2 mitochondrial autoantigens in normal human sera by immunofluorescence and novel assays. J Gastroenterol Hepatol. 1996;11: 610-616.
30. Muratori P, Muratori L, Gershwin ME, et al. "True" anti-mitochondrial antibody-negative primary biliary cirrhosis: low sensitivity of the routine assays or both? Clin Exp Immunol. 2004;135:154-158.
31. Czaja AJ, Carpenter HA. Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology. 1993;105:1824-1832.
32. Czaja AJ, Carpenter HA, Santrach PJ, et al. Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology. 2000;31:1231-1238.
33. Czaja AJ, Carpenter HA. Autoimmune hepatitis with incidental histologic features of bile duct injury. Hepatology. 2001;34: 659-665.
34. Soloway RD, Baggenstoss AH, Schoenfield LJ, et al. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis. 1975;20: 1087-1090.
35. Czaja AJ, Davis GL, Ludwig J, et al. Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis. Hepatology. 1984;4: 622-627.
36. Summerskill WHJ, Korman MG, Ammon HV, et al. Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut. 1975;16: 876-883.
37. Czaja AJ, Wolf AM, Baggenstoss AH. Laboratory assessment of severe chronic active liver disease (CALD): correlation of serum transaminase and gamma globulin levels with histologic features. Gastroenterology. 1981;80:687-692.
38. Czaja AJ, Menon KVN, Carpenter HA. Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis. Hepatology. 2002;35:890-897.
39. Donaldson PT, Doherty DG, Hayllar KM, et al. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology. 1991;13:701-706.
40. Gores GJ, Moore SB, Fisher LD, et al. Primary biliary cirrhosis: associations with class II major histocompatibility complex antigens. Hepatology. 1987;7:889-892.
41. Manns MP, Bremm A, Schneider PM, et al. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology. 1991;101:1367-1373.
42. Stone J, Wade JA, Cauch-Dudek K, et al. Human leukocyte antigen class II associations in serum antimitochondrial antibodies (AMA)-positive and AMA-negative primary biliary cirrhosis. J Hepatol. 2002;36:8-13.
43. Donaldson PT, Baragiotta A, Heneghan MA, et al. HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology. 2006;44:667-674.
44. Czaja AJ, Carpenter HA, Moore SB. Clinical and HLA phenotypes of type 1 autoimmune hepatitis in North America outside DR3 and DR4. Liver Int. 2006; 26:552-558.
45. Czaja AJ, Strettell MDJ, Thomson LJ, et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology. 1997;25:317-323.
46. Djilali-Saiah I, Fakhfakh A, Louafi H, et al. HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis. J Hepatol. 2006;45:844-850.
47. Muratori P, Czaja AJ, Muratori L, et al. Evidence of a genetic basis for the different geographical occurrences of liver/kidney micro-somal antibody type 1 in hepatitis C. Dig Dis Sci. 2007;52:179-184.
48. Czaja AJ, Santrach PJ, Moore SB. Shared genetic risk factors in autoimmune liver disease. Dig Dis Sci. 2001;46:140-147.
49. Alarcon-Segovia D. Shared autoimmunity: a concept for which the time has come. Autoimmunity. 2005;38:201-203.
50. Czaja AJ. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a foray across diagnostic boundaries. J Hepatol. 2006;44:251-252.
51. Heathcote J. Variant syndromes of autoimmune hepatitis. Clin Liver Dis. 2002;6:669-684.